A $540 value
In relation to the risk of developing cancer, a study published in The Journal of Clinical Endocrinology & Metabolism found no significant association between the dose of rhGH, mortality, and cancer incidence, making causality far less likely: Safety concerns have been raised regarding premature mortality, diabetes, neoplasia, and cerebrovascular disease in association with GH therapy
anti-Tom20, SANTA #sc-17764 1:1000
The research team suggested that semaglutide's unique pharmacological properties, including its long residence time in the body and partial penetration into the brain, may explain the finding
We changed pharmacy vendor, now you cant get it unless you have had a history of diabetes. Senior Benefits Manager, large manufacturer Weve never offered it for weight loss, and it is still one of our top three prescriptions spends every year. HR Professional, large manufacturer We dont allow GLP-1s for weight loss In our type 2 diabetes population, 50% are utilizing the GLP-1s, so we are now excluding them for anything except type 2 diabetes [to manage costs]. Director of Benefits, large manufacturer The future of GLP-1 drug prices Employers are also recognizing that the price paid by employers for GLP-1 drugs are sometimes higher than online direct-to-consumer prices reflecting manufacturer discounts
PlexusDx can adjust your treatment protocol at this stage to maximize results or modify the approach based on your individual response
